Features of recombinant antibody production services
Recombinant antibody production is a key technology for the industrialization of monoclonal antibodies. Without the need for immunization and screening procedures, the antibody gene sequences can be directly used to stably produce a large number of antibodies. BIM has a complete antibody recombination production platform and has extensive experience in large-scale production of recombinant antibodies. It can provide rapid production of recombinant antibodies from milligrams to kilograms to meet customers' high-throughput and large-scale production requirements.
Advantages of recombinant antibody production services
The high-efficiency culture medium and transfection reagent independently developed by the company have high expression vectors and engineering cell lines with independent intellectual property rights, ensuring high success rate of antibody production at low cost.
From shake flasks to bioreactors of different sizes, 24 hours a day, 7 days a week, to ensure rapid antibody production.
It can provide transient transfection to produce antibodies, and develop antibody-expressing stable cell lines to meet different customer needs.
It can express full-length subtype antibodies (IgG1, IgG2a, IgG2b, IgG3, IgG4, IgM, etc.), chimeric antibodies (human mouse chimeric, pika chimeric, etc.), and can also express antibody fragments (Fab, scFv, nanobody). Wait).
Customize high-purity, high-concentration, low-endotoxin antibodies according to customer requirements.
Available from monoclonal antibody preparation - Hybridoma antibody gene sequencing - Mouse antibody production - Chimeric antibody production - Antibody humanization - Affinity maturation - Antibody characterization - Process development - GMP production One-stop service.
Recombinant antibody production service process